Novartis (NVS)
(Delayed Data from NYSE)
$99.06 USD
+0.71 (0.72%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $99.07 +0.01 (0.01%) 7:22 PM ET
3-Hold of 5 3
B Value D Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/16/24 |
---|---|
Current Quarter | 1.81 |
EPS Last Quarter | 1.80 |
Last EPS Surprise | 4.05% |
ABR | 2.45 |
Earnings ESP
|
1.66% |
---|---|
Current Year | 7.22 |
Next Year | 7.98 |
EPS (TTM) | 6.90 |
P/E (F1) | 13.62 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.82B | 11.96B | 48.28B | 50.80B |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 11.99B | 12.23B | 50.10B | 53.88B |
Low Estimate | 11.68B | 11.78B | 47.24B | 49.33B |
Year ago Sales | 13.62B | 11.78B | 49.78B | 48.28B |
Year over Year Growth Est. | -13.20% | 1.55% | -3.01% | 5.22% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.81 | 1.83 | 7.22 | 7.98 |
# of Estimates | 2 | 1 | 7 | 6 |
Most Recent Consensus | NA | NA | 7.20 | NA |
High Estimate | 1.84 | 1.83 | 7.38 | 8.31 |
Low Estimate | 1.78 | 1.83 | 7.05 | 7.65 |
Year ago EPS | 1.83 | 1.74 | 6.90 | 7.22 |
Year over Year Growth Est. | -1.09% | 5.17% | 4.64% | 10.51% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 3 | 1 |
Up Last 30 Days | 0 | 0 | 3 | 2 |
Up Last 60 Days | 0 | 0 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 2 | 2 |
Down Last 60 Days | 1 | 0 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.81 | 1.83 | 7.22 | 7.98 |
7 Days Ago | 1.78 | 1.83 | 7.15 | 7.97 |
30 Days Ago | 1.80 | 1.85 | 7.17 | 8.00 |
60 Days Ago | 1.80 | 1.85 | 7.18 | 8.00 |
90 Days Ago | 1.81 | 1.86 | 7.32 | 8.01 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.84 | 1.83 | 7.25 | 8.11 |
Zacks Consensus Estimate | 1.81 | 1.83 | 7.22 | 7.98 |
Earnings ESP | 1.66% | 0.00% | 0.42% | 1.57% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.80 | 1.53 | 1.74 | 1.83 | NA |
Estimate | 1.73 | 1.64 | 1.70 | 1.68 | NA |
Difference | 0.07 | -0.11 | 0.04 | 0.15 | 0.04 |
Surprise | 4.05% | -6.71% | 2.35% | 8.93% | 2.16% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more